Skip to main content
. 2018 Dec 6;34(10):700–709. doi: 10.1089/jop.2018.0062

Table 3.

Visual Outcomes After Intraocular Inflammation Adverse Events

Intraocular inflammation AE (MedDRA preferred term) Treatment arm Worst change from baseline BCVA after AE (letters) BCVA change from baseline at escape to SoC or study exit (letters)
Iritis Abicipar 1 mg −5 −1
Uveitis Abicipar 1 mg −2 +4
Vitritis Abicipar 1 mg +14 +22
Iritis Abicipar 2 mg NA +2
Choroiditis Abicipar 2 mg −19 +7

AE, adverse event; BCVA, best-corrected visual acuity; MedDRA, medical dictionary for regulatory activities; NA, not available; SoC, standard of care.